Many genes in dystroglycan signaling pathway, including POMT140 and FKTN41, have been found to contribute to the pathogenesis of dystroglycanopathies. Here, DAG1 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.